Hesi Review Care of Patient With Acute Coronary Syndrome Chapter 38
Ann Transl Med. 2016 Jul; iv(thirteen): 256.
Epidemiology of coronary heart illness and acute coronary syndrome
Fabian Sanchis-Gomar
1Enquiry Establish of the Hospital 12 de Octubre ('i+12'), Madrid, Spain;
Carme Perez-Quilis
1Inquiry Institute of the Infirmary 12 de Octubre ('i+12'), Madrid, Spain;
Roman Leischik
twoFaculty of Health, School of Medicine, Academy Witten/Herdecke, Hagen, Germany;
Alejandro Lucia
aneEnquiry Institute of the Hospital 12 de Octubre ('i+12'), Madrid, Spain;
3European University of Madrid, Madrid, Spain
Received 2016 May 21; Accustomed 2016 May 24.
Abstract
The aim of this review is to summarize the incidence, prevalence, trend in bloodshed, and full general prognosis of coronary centre illness (CHD) and a related condition, acute coronary syndrome (ACS). Although CHD mortality has gradually declined over the last decades in western countries, this condition nevertheless causes about one-third of all deaths in people older than 35 years. This evidence, along with the fact that bloodshed from CHD is expected to continue increasing in developing countries, illustrates the need for implementing effective principal prevention approaches worldwide and identifying risk groups and areas for possible improvement.
Keywords: Cardiovascular illness (CVD), mortality, myocardial infarction (MI), sudden cardiac death (SCD)
Introduction and definitions
Cardiovascular disease (CVD) is a grouping of diseases that include both the heart and claret vessels (ane), thereby including coronary center disease (CHD) and coronary artery disease (CAD), and acute coronary syndrome (ACS) among several other weather condition. Although health professionals frequently use both terms CAD and ACS interchangeably, equally well every bit CHD, they are non the aforementioned. ACS is a subcategory of CAD, whilst CHD results of CAD. On the other hand, CAD is characterized past atherosclerosis in coronary arteries and can exist asymptomatic, whereas ACS nigh always presents with a symptom, such as unstable angina, and is frequently associated with myocardial infarction (MI) regardless of the presence of CAD (ii). Finally, CAD is usually used to refer to the pathologic process affecting the coronary arteries (usually atherosclerosis) whilst CHD includes the diagnoses of angina pectoris, MI and silent myocardial ischemia (iii). In plough, CHD mortality results from CAD. For simplicity purposes, herein we volition refer to CAD as CHD. Indeed, the development of novel and more sensitive immunoassays (i.e., defined as "high-sensitivity") for measuring cardiac troponins has contributed to substantially revised this classification, wherein the spectrum of clinical conditions previously defined as "unstable angina" has at present been progressively reclassified as either non-MI or MI (4).
CHD is a major cause of decease and disability in adult countries (5). Although the mortality for this condition has gradually declined over the last decades in western countries, it still causes about i-third of all deaths in people older than 35 years (half-dozen-8). The Framingham Heart Study perfectly summarizes the chance factors that contribute to the development of CHD, providing critical information regarding objectives for the primary and secondary prevention of CHD.
The list of non-communicable diseases is becoming larger and more complex. Rapid globalization, urbanization, ageing of gild, and an increase in chronic diseases pose new challenges to modern health intendance systems (ix,10). CVD is preventable, merely concrete inactivity, nicotine corruption and bad nutrition practices (11) (lost of traditional diet habits in new-industrial cultures) are leading to an increment of prevalence in nigh countries (12). Further, social inequalities increase CVD-mortality (12-14) and negative lifestyle influences such as increased concrete inactivity in more than "obesogenic" environment (14) are reverting the improvements in CVD data that were obtained in some countries (15).
Two common measures of disease burden in a population, incidence and prevalence, are defined as follows. Incidence is the number of new cases of a affliction over a menstruum of fourth dimension divided past the population at risk, whereas prevalence is the number of existing cases of a affliction divided by the total population at a point in time. In this review, we summarize the incidence, prevalence, tendency in bloodshed, and general prognosis of CHD and ACS.
Incidence, prevalence, trends in mortality, and prognosis of CHD
The 2016 Heart Disease and Stroke Statistics update of the American Center Association (AHA) has recently reported that 15.5 one thousand thousand persons ≥20 years of age in the USA have CHD (16), whilst the reported prevalence increases with age for both women and men and it has been estimated that approximately every 42 seconds, an American will suffer for an MI (see Figure 1 for a summary of representative data).
Some examples of representative recent epidemiology data on CHD and MI in the USA. The effigy is generated with hard data previously published in Mozaffarian et al. (16). CHD, coronary heart disease; MI, myocardial infarction.
Although the absolute numbers of CVD deaths take significantly increased since the 1990, the historic period-standardized expiry rate has decreased by 22% over the aforementioned menstruum, primarily due to a shift in age demographics and causes of death worldwide (17). In a 2009 report that used National Health and Nutrition Examination Survey (NHANES) data, MI prevalence was compared by sex activity in middle-aged individuals (35–54 years) during the 1988–1994 and 1999–2004 fourth dimension periods (18). The prevalence of MI was higher in men compared with women in the two periods, simply it tended to decline in the sometime over time, whilst the opposite trend was found in women. Some data based on self-reported MI and angina from health interviews, such as those from the NHANES, might underestimate the bodily prevalence of advanced CHD. This is probable to be due, at least partly, by the fact that advanced occlusive CHD often exists with few symptoms or overt clinical manifestations. Silent ischemia, which accounts for 75% of all ischemic episodes (19), may be brought to light past electrocardiographic (ECG) changes on an practise test (i.e., ST-segment depression), ambulatory 24-hour ECG recording, periodic routine ECG or cardiac troponins testing. Autopsy information have reported a reduced prevalence of anatomic CHD over fourth dimension in both the general population and military personnel.
In an report which included 2,562 autopsies performed between 1979 and 1994, the prevalence of anatomically-axiomatic CHD in subjects anile 20–59 years fell from 42% to 32% in men and from 29% to 16% in women when the periods 1979–1983 and 1990–1994 were compared (20). In that location was no significant change in prevalence in those aged threescore years or older. In an analysis of 3,832 autopsies performed on U.s.a. war machine personnel (98% male, mean historic period 26 years) who died during combat or due to unintentional injuries between October 2001 and August 2011, the prevalence of CHD was 8.5% (21). This represents a marked pass up in the prevalence of dissection-documented CHD compared with the rates seen during the Korean War in the 1950s (77%) and the Vietnam War in the 1960s (45%) (21).
Data from 44 years of follow-up in the original Framingham Study accomplice and 20 years of surveillance of their offspring has allowed observation of the incidence of initial coronary events such as MI (whether clinically recognized or not), angina pectoris, unstable angina, and sudden and non-sudden coronary deaths (22-24), reporting the following observations. First, for people aged 40 years, the lifetime risk of developing CHD was 49% in men and 32% in women whereas for those reaching age 70 years, the lifetime adventure was 35% in men and 24% in women. On the other hand, for total coronary events, the incidence rose steeply with age, with women lagging behind men by 10 years whilst for the more serious manifestations of CHD, such as MI and sudden death, women lagged behind men in incidence by 20 years, but the sex ratio for incidence narrowed progressively with advancing age (7). The incidence at ages 65–94 years compared to ages 35–64 years more than doubled in men and tripled in women, respectively. Third, serious CHD manifestations (i.due east., MI, sudden death) were exceptional in premenopausal women and the brunt of CHD was markedly college amid postmenopausal women compared to their premenopausal age-matched referents (22). Fourth, beneath 65 years of historic period, the almanac incidence of all coronary events in men (12 per 1,000) more than equaled the rate of all the other atherosclerotic cardiovascular events combined (7 per 1,000); in women, it equaled the rate of the other events (five per 1,000). Beyond 65 years of age, CHD was still predominant. Coronary events comprised 33% to 65% of atherosclerotic cardiovascular events in men and 28% to 58% in women. Finally, the fact that angina pectoris was more frequent in men compared with women was less striking. In women aged <75 years, angina pectoris was more frequent than MI as the initial presentation of CHD (23). Furthermore, angina in women was more likely to be elementary (80%), while angina in men frequently occurred after a MI (66%). MI predominated at almost all ages in men in whom only 20% of events were preceded by long-continuing angina; the per centum was fifty-fifty lower for silent or unrecognized MI (23,24).
In addition to sex activity, other factors may influence whether the initial presentation of CHD is an acute MI or stable angina. A case command study of adults with a start clinical presentation of CHD as either astute MI (n=916) or stable exertional angina (n=468) suggested that contempo prior therapy with statins and beta blockers affect the clinical presentation (25).
The incidence of CHD has decreased over time in developed countries. Several reports have illustrated this tendency. Start, in an analysis from the NHANES I Epidemiologic Follow-up study, in which two cohorts of subjects were compared from 1971 to 1982 (ten,869 patients) and from 1982 to 1992 (9,774 patients) (26), the incidence of CHD decreased from 133 to 114 cases per 10,000 persons per twelvemonth of follow-up. An even larger reject was seen in overall CVD (from 294 to 225 cases per 10,000 persons per year). A written report from the Mayo Clinic examined the incidence of CHD over time in Olmsted County (Minnesota) (27). During the interval from 1988 to 1998, there was a declining trend in the age-adjusted incidence of whatever new CHD (MI, sudden decease, unstable angina, or angiographically-diagnosed CHD) from 57 to 50 cases per 10,000 persons [relative take chances (RR) 0.91; 95% confidence interval (CI): 0.82–1.01]. On the other hand, CVD mortality has been failing recently in the United states and in regions where economies and health care systems are relatively advanced, but the experience is oftentimes quite dissimilar around the globe (28). Indeed, CHD is the number i crusade of death in adults from depression-, eye- and high-income countries (29). At the plow of the century, it was reported that CHD bloodshed was expected to increase approximately 29% in women and 48% in men in adult countries between 1990 and 2020; the corresponding estimated increases in developing countries were 120% in women and 137% in men (30). On the other hand, the well-nigh dramatic increments in CHD events on a percentage basis are forecast for the Centre East and Latin America. The experience in Asia is especially important considering of the large populations involved. The post-obit are examples of differing observations made across geographic regions. In a 2014 report using Earth Health Organization (WHO) data from 49 countries in Europe and northern Asia, over 4 one thousand thousand annual deaths were due to CVD (8). In India, CHD may not be largely explained by traditional risk factors (31). In China, risk factor trends complement tracking of event rates. For case, the dramatic increase in CHD mortality in Beijing is attributable to higher cholesterol levels. The mean cholesterol level was iv.thirty mmol/L (166 mg/dL) in 1984 but rose to 5.33 mmol/50 (206 mg/dL) only fifteen years afterwards (32). In Latin America, declines in CVD rates take been less favorable than in the United states of america, with more unhealthy trends in physical action, obesity, and smoking contributing to these differences (33). Thus, international leaders accept called for action plans to avert the projected global epidemic of CHD in developing countries (34).
Given the progression of atherosclerosis over decades, patients are typically asymptomatic for years in spite of the evidence of CHD. Despite lack of symptoms, the presence and extent of non-obstructive CHD are associated with a worse prognosis compared with patients with no evidence of CHD (35,36). In a retrospective accomplice written report of 37,674 USA veterans (96% male) without prior CHD events who underwent coronary angiography between October 2007 and September 2012 and were followed for one yr, the risk of MI increased significantly and progressively in parallel with the extent of both non-obstructive (at least one stenosis ≥20% but <70%) and obstructive CHD (at least one stenosis ≥70%) (35). Compared with patients without CHD, the risk of MI trended higher for patients with i vessel non-obstructive CHD [hazard ratio (Hour) 2.0; 95% CI: 0.eight–v.1] and was significantly greater for patients with non-obstructive CHD involving two (Hr 4.half-dozen; 95% CI: 2.0–x.5) or three heart vessels (Hour 4.five; 95% CI: 1.6–12.5). Finally, patients with non-obstructive CHD should be considered for usual secondary prevention measures (37).
What about MI?
Relatively few population-based studies have examined contempo temporal trends in the incidence of MI, whether overall and by blazon, and more gimmicky assessments of epidemiology of MI are needed to assist assess the effectiveness of primary prevention and identify areas for potential improvement (38). Despite the declining incidence of CHD in the The states reported in the quondam section of this commodity, many (26,39-41), but not all (42,43), observational studies take establish no reduction in the incidence of MI in a variety of fourth dimension periods including 1971–1982 and 1982–1992 (26), 1975–1997 (39), 1994–1999 (40), and 1987–2006 (43). In a study of 5,832 Massachusetts patients with acute MI seen betwixt 1975 and 1997, the incidence of MI was like in 1975–1978 and 1997, respectively (230 per 100,000 people in both periods) (39). In a study of 2,816 cases of MI from 1976 to 2006 in Olmsted County, Minnesota, the incidence of MI decreased by 20% (186 to 141 per 100,000 population) when data of the predominant cardiac isoform of creatine kinase (CK-MB) in blood were applied (43). Withal, the employ of the more than sensitive troponin assays, which began after the year 2000 and permits the diagnosis of MI when a lower area of the myocardium is infarcted compared to CK-MB, could take potentially masked an actual reduction in MI incidence over fourth dimension (44). All the patients included in the studies above, with the exception of the Olmsted County report, experienced their MI before 2000, and this potential problem does non apply to them. Approximately one quarter of MI did non meet CK-MB criteria later the introduction of troponin testing (43).
Several studies take assessed the influence of sex, race or historic period on the epidemiology of MI. The Atherosclerosis Gamble in Communities (ARIC) written report focused on the run a risk of CHD events among 360,000 residents aged 35–74 years in 4 communities: Forsythe County, North Carolina; Jackson, Mississippi; Minneapolis, Minnesota; and Washington County, Maryland (45,46). Between 1987 and 1996, a total of 14,942 hospitalized patients with definite or likely MI were identified. The historic period-adjusted incidence of hospitalized MI was highest in black men and everyman amongst white women Although the age-adjusted incidence of first MI was relatively stable during 1987–1996 in both genders for white people (with non-meaning trends to increase by 1.ane% and 1.seven% per twelvemonth in men and women, respectively), it did increment significantly in black people (4.ane% and 3.9% per year, respectively). Although the study also showed a subtract in recurrent MI in both genders (−1.9% and −2.1% per yr, respectively), it was underpowered to assess differences based on race or ethnicity. Finally, instance-fatality rates later MI decreased significantly during the 1987–1996 period in both genders, i.e., past −6.1% and −six.2%, respectively. The authors hypothesized that improvements in CHD outcome were mostly attributable to secondary rather than to main prevention strategies (45-47). The Worcester Heart Attack Study has followed upwardly a community based accomplice of residents of Worcester, Massachusetts, for cardiovascular events (27,48-51). On the other paw, data from ARIC customs surveillance suggests that the severity of acute MI has declined amongst customs residents hospitalized for incident MI, which is ane of the factors explaining the overall decline in CHD-related mortality (52).
In a study of patients hospitalized with MI betwixt 1975 and 1995, the age-adjusted incidence of first MI increased initially between 1975 and 1981 (to a peak of 272 cases per 100,000), and then decreased until 1990, before having a slight increment again until 1995 (184 cases per 100,000). Among the trends observed over time, an increase in the median historic period of patients presenting with MI and an increase in the proportion of patients who were women, had diabetes, or had hypertension were noticed. There was no observed decrease in the crude long-term mortality rates after MI during the written report period. However, when adjusted for temporal changes in CVD risk factors, in that location was a higher ane-yr survival rate in the patients presenting in 1993 and 1995 compared with those presenting in 1975 or 1978 (RR, 1.56; 95% CI: 1.13–2.xvi), although the tendency was not consistent during the entire menstruum (27,48-51).
In that location has been a relative increase in not-ST peak MI (NSTEMI) in relation to ST elevation MI (STEMI) with time (39,forty,43). For example, a report from the National Registry of MI 1 to 5 reviewed over 2.5 1000000 MI cases between 1990 and 2006 (40) and establish that the proportion of MI due to NSTEMI increased from 19% in 1994 to 59% in 2006. This alter in proportion was associated with an absolute decrease in the incidence of STEMI and either a ascent (using MI defined with CK-MB or cardiac troponin criteria) or no change in the charge per unit of NSTEMI (using MI defined with CM-MB criteria only) (43). Within a big community-based population, the incidence of MI decreased significantly after 2000, and the incidence of STEMI decreased markedly later on 1999 (53). Reductions in brusque-term example fatality rates for MI are due, at least partly, to a subtract in the incidence of STEMI, a lower rate of expiry after NSTEMI (53), just also to the enhanced diagnostic effectiveness of modernistic cardiac troponin immunoassays for detecting minor myocardial injury.
Although many cases of MI appear to occur without warning, in that location is a big reservoir of detectable advanced silent CHD from which these plainly sudden events evolve. Such patients frequently have an ominous coronary risk profile and signs of pre-symptomatic CHD. Approximately 2–4% of the general population has silent coronary ischemia which despite being an asymptomatic status tin can be actually detected with an exercise test or ambulatory ECG monitoring. The prevalence of this condition might be considerable college in men with 2 or more major coronary risk factors (10%), and especially in patients with known CHD, e.g., 25–l% in those with stable angina detected through exercise testing or ambulatory monitoring (54).
The most specific indicator of the beingness of silent myocardial ischemia in ECG recordings is a Q-wave MI (55). In a serial of reports from the Framingham Centre Study, the following observations were fabricated almost silent MI. First, amongst patients who had suffered a new MI during routine biennial ECG, the infarct was silent in 26% of men and 34% of women, respectively (56). In men, the frequency of unrecognized MI was higher in diabetic than in non-diabetic individuals (39% vs. 18%) (57). Other big epidemiologic studies reported an overall comparable proportion of silent MI in both genders (33% of MI in men vs. 33–54% in women) (58-60). On the other paw, the short-term (<30 day) mortality after Q-wave MI has declined over the decades, but this remains to be corroborated for long-term sequelae. A study showed that substantial reductions in risk of CHD death and all-cause bloodshed occurred over the final decades of the previous century after Q-wave MI, coincident with improvements in post-MI therapies and in post-MI survival of individuals with depressed LV systolic part (61).
Silent MI, like clinically credible MI, is strongly associated with age, as reflected by information of 9,141 men (48) and 13,000 women followed for 4–20 years in the Reykjavik Written report (58): for instance, the incidence went from ~0 (for those anile ~40 years) to three per 1,000 man-year at historic period 60. The incidence of unrecognized MI might have been underestimated in the aforementioned biennial population-based estimates for at least two reasons: about 10% of anterior and 25% of inferior ECG MI revert to a non-diagnostic blueprint within two years afterwards the event, and some unrecognized MI precipitate sudden death before they can be discovered (e.g., type 3 MI) (62,63).
In addition to the development of new Q-waves, other ECG signs that might reverberate silent CHD or an increased risk of CHD/CVD mortality are evidence of left ventricular (LV) hypertrophy (LVH), intra-ventricular conduction disturbances, and nonspecific repolarization abnormalities. The ECG evidence of LVH had a prognosis just as serious as the ECG prove of MI in the Framingham Study (64,65). Echocardiography is more sensitive than ECG for detection of LVH. Marked departure of the frontal T-moving ridge axis (−180º to −15º and 105º to 180º) is indicative of a disturbance in ventricular repolarization and appears to be a predictor of CHD events and mortality in older subjects (66,67). The potential magnitude of this effect was illustrated in the Rotterdam written report of 4,781 patients aged ≥55 years who were followed for a mean of iv years. The presence of T-wave centrality divergence was found to increase the risk of cardiac expiry (HR 3.9), sudden death (60 minutes 4.4), and nonfatal cardiac events (HR 2.seven) (66).
The coronary take chances cistron profiles of individuals with previously unrecognized MI is similar to that of patients with clinically recognized MI (55). However, two CVD risk factors, hypertension and diabetes mellitus, are associated with a higher likelihood of having unrecognized MI. Indeed, both unrecognized and recognized MI go more incident with severe hypertension, but the proportion of unrecognized MI is considerably higher in hypertensive people compared to their normotensive peers (68). This trend persisted fifty-fifty when excluding from the analyses patients with diabetes or LVH, or those receiving antihypertensive therapy. On the other hand, diabetes was confirmed by the Framingham Study as a risk factor for silent infarction in men but not in women (57). In men with diabetes, the fraction of MI that were unrecognized was more two times higher than in those without (39% vs. 18%); in comparison, women with diabetes in this study (36) as well as in the Eye and Estrogen/progestin Replacement Written report (HERS), were less likely to have unrecognized MI (57,69).
The long-term outcomes of individuals with established CHD accept been evaluated with special attention to sexual practice differences. In a survey from Rochester (MN, Usa) including patients seen between 1960 and 1979, women with angina pectoris as an initial diagnosis had a longer survival and lower risk of subsequent MI or cardiac decease than age-matched men with the same presentation (70). This difference did not utilise to presentations with MI or sudden cardiac arrest. A later analysis from Republic of finland suggested that the prognosis may non exist different in women (71). Data were collected on about 120,000 patients aged 45–89 years who had new onset of "nitrate angina" or "examination-positive angina". Nitrate angina was associated with a similar increment in coronary mortality at 4 years compared to the general population in both women and men at every age grouping. However, among patients anile <75 years and with test-positive angina, the coronary bloodshed ratio was higher in women. Among elderly women and men, exertional chest pain has been linked with the same increase in RR of coronary just not of non-coronary mortality (72). The incidence/prevalence of MI increases progressively in older women, especially later on the age of 45 (73). Women with a beginning symptomatic MI are unremarkably ~6–10 years older than men (by half-dozen to 10 years) (74) as well as more likely to have a history of diabetes, hypertension, hyperlipidemia, center failure, and an unstable angina design (74,75).
Several studies have specifically evaluated the outcomes in women with ACS and no ST elevation [unstable angina or NSTEMI (non-Q moving ridge)]. Despite more comorbidities, these women have a like (76) or better outcome than men (77-79). In the Global Use of Strategies to Open up Occluded Coronary Arteries in Astute Coronary Syndromes IIb report, which evaluated 12,142 patients with ACS, there was no outcome difference betwixt genders when considering NSTEMI patients, while women with unstable angina had a lower rate of decease or re-infarction [odds ratio (OR) 0.65] (78). Like findings were reported in some other study of 2,271 patients who were followed for six years subsequently they presented to the emergency department for the start time with unstable angina (79). Later on multivariate analysis, women had a trend toward a lower gamble of decease (RR, 0.81) and a significantly reduced run a risk for a cardiac upshot (RR, 0.83).
CHD: cause of expiry
CHD is the leading cause of death in adults in the U.S., accounting for ~one-third of all deaths in subjects over age 35 (seven). The 2016 Heart Disease and Stroke Statistics update of the AHA reported that overall death rate from CHD was 102.6 per 100,000 (16). Moreover, from 2003 to 2013, the annual death rate owing to CHD declined 38.0% and the actual number of deaths declined 22.9% (16).
Although the tendency has tended to reach a plateau since 1990, the overall mortality rates for CVD and CHD have fallen in most developed countries (by 24–50%) since the 1975 (7,26,46,50,80-87). The causes for reduction in CHD mortality were evaluated in adults aged 25–84 years in the USA during the 1980–2000 period (85), and the post-obit chief findings arose. Beginning, approximately one-half of this consequence was accounted for factors similar improvements in therapy, including secondary preventive measures after MI or revascularization, initial treatments for ACS, therapy for heart failure, and revascularization for chronic angina deemed for approximately half of the refuse in CHD bloodshed. The other half of this effect was due to changes in risk factors, including reductions in full cholesterol (24%), systolic blood pressure (20%), smoking (12%), and physical inactivity (5%). However, the aforementioned reductions were partly offset past increases in body mass alphabetize and in the prevalence of diabetes (88). Similar trends toward an effect improvement in adult countries accept been described in an analysis of decease certificates from the WHO database (89). The following findings were noted for the 1965–1969 and 1995–1997 periods. First, in the USA, CHD mortality fell by 63% in men (331 to 121 per 100,000) and by 60% in women (166 to 67 per 100,000). In the European Matrimony, CHD mortality brutal by 32% in men (146 to 100 per 100,000) and by 30% in women (64 to 45 per 100,000). In that location was some variability in Eastern Europe, with some countries showing an increase in CHD mortality in the early 1990s followed by a subsequent reject (Poland and the Czech republic). The highest CHD mortality was found in the Russia, i.due east., 330 and 154 per 100,000 in men and women, respectively, for the 1995–1998 menstruation, with these values existence still like to those for 1985–1989. In Japan, CHD mortality was much lower than in the USA or Europe, and fell by 29% in men (50 to 36 per 100,000) and by 36% in women (28 to 18 per 100,000), respectively. Dissimilar the above data, mortality from CHD is expected to increment in developing countries (Prc, India, sub-Saharan Africa, Latin America, and the Center East), from an estimated ix million in 1990 to a projected 19 million by 2020 (90,91). This phenomenon is to be expected as a upshot of social and economical changes in these countries, resulting in higher life expectancy, Westernized diets, concrete inactivity, increases in cigarette smoking and ecology pollution (32).
Sudden cardiac death (SCD)
There is a strong relationship between SCD and CHD (92). Clinical and mail-mortem studies as well every bit information from death certificates revealed that 62–85% of patients who suffer out-of-hospital SCD have show of prior CHD, x% take other structural cardiac abnormalities, and 5% have no structural cardiac aberration (93,94). A surveillance study of SCD from Ireland concluded that the majority of cases occurred in home and that successful resuscitation of SCD was especially associated with ventricular fibrillation as presenting rhythm (95). A recent report reported bear witness for the occurrence of active Coxsackie B viral infections in people who died of MI compared to controls, and the authors suggested that an underlying machinery might be disruption of dystrophin in endomyocardial tissue (96).
SCD is the initial clinical coronary event in xv% of patients with CHD (76). In addition, SCD is the almost frequent type of expiry in patients with CHD, bookkeeping for 30% to 50% of events (97,98). The incidence of SCD after acute MI is the same with STEMI and NSTEMI (99), likewise as with symptomatic and silent MI (100). Among patients who have had an MI and are followed for nigh four years, approximately one-half of sudden deaths occur in the first twelvemonth and 1-quarter in the first three months (101,102). The hazard is peculiarly loftier in patients with a LV ejection fraction ≤35%. On the other hand, although the risk of SCD is the highest in patients with a history of prior resuscitated SCD, MI or middle failure, approximately 80% of SCD events occur in asymptomatic patients with no such history (103). Among patients with CHD, the sudden death risk in women is half that in men, and in asymptomatic persons the chance for SCD is mostly proportional to hazard of CVD, with the incidence lags behind men by more than ten years (98). In both sexes, MI doubles the risk of SCD compared with angina (98,100). In the Oregon Sudden Unexpected Death Written report (Ore-SUDS) of over 1,500 cases of sudden cardiac abort, the post-obit main findings were noted (104). Get-go, at that place was no significant gender effect in the prevalence of obesity, dyslipidemia, LVH, or history of MI. Second, women had a significantly less risk of having severe LV dysfunction (OR 0.51) or CHD (OR 0.34). The outcome of women who experienced an episode of out-of-hospital SCD was examined in a retrospective cohort study of 9,651 men and women (105). Women were less likely than men to have ventricular fibrillation as an initial rhythm dysfunction (25% vs. 43%) and were more likely to accept pulseless electrical activity/asystole (73% vs. 55%). After adjusting for presence of ventricular fibrillation and other factors, women had a like rate of survival to hospital discharge (29% vs. 28%).
Conclusions and perspectives
Although CHD bloodshed rates accept declined over the past four decades in western countries, this condition remains responsible for ~ane-3rd of all deaths in individuals over age 35. Nearly one-one-half of all center-aged men and one-tertiary of heart-aged women in the USA will develop some manifestation of CHD. The 2016 Center Affliction and Stroke Statistics update of the AHA reported that 15.5 million people in the USA. have CHD. The reported prevalence increases with age for both women and men. For those Us people, the lifetime risk of developing CHD with ≥2 major risk factors is 37.5% for men and 18.3% for women. CVD disease mortality has been declining in the United states and in regions where economies and health care systems are relatively avant-garde, but the feel is often quite different effectually the globe.
Acknowledgements
Funding: The enquiry of AL is funded past the Fondo de Investigaciones Sanitarias (FIS, grant # PI12/00914 and) and co-financed by Fondos FEDER.
Footnotes
Conflicts of Interest: The authors take no conflicts of interest to declare.
References
1. Global Atlas on Cardiovascular Illness Prevention and Control. Geneva: Earth Wellness Organization, 2011. [Google Scholar]
2. Lippi K, Sanchis-Gomar F, Cervellin M. Chest hurting, dyspnea and other symptoms in patients with type i and 2 myocardial infarction. A literature review. Int J Cardiol 2016;215:xx-ii. ten.1016/j.ijcard.2016.04.045 [PubMed] [CrossRef] [Google Scholar]
3. Cervellin K, Lippi G. Of MIs and men--a historical perspective on the diagnostics of acute myocardial infarction. Semin Thromb Hemost 2014;40:535-43. ten.1055/s-0034-1383544 [PubMed] [CrossRef] [Google Scholar]
4. Cervellin Chiliad, Mattiuzzi C, Bovo C, et al. Diagnostic algorithms for astute coronary syndrome-is 1 ameliorate than another? Ann Transl Med 2016;4:193. 10.21037/atm.2016.05.16 [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
six. Rosamond W, Flegal Thou, Furie K, et al. Center disease and stroke statistics--2008 update: a report from the American Heart Clan Statistics Committee and Stroke Statistics Subcommittee. Apportionment 2008;117:e25-146. 10.1161/CIRCULATIONAHA.107.187998 [PubMed] [CrossRef] [Google Scholar]
7. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart affliction and stroke statistics--2010 update: a report from the American Middle Association. Apportionment 2010;121:948-54. x.1161/CIRCULATIONAHA.109.192666 [PubMed] [CrossRef] [Google Scholar]
8. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014;35:2929. x.1093/eurheartj/ehu378 [PubMed] [CrossRef] [Google Scholar]
9. Horton R. Offline: Chronic diseases—the social justice issue of our time. Lancet 2015;386:2378 10.1016/S0140-6736(15)01178-2 [CrossRef] [Google Scholar]
10. Danaei G, Singh GM, Paciorek CJ, et al. The Global Cardiovascular Gamble Transition: Associations of 4 Metabolic Adventure Factors with National Income, Urbanization, and Western Nutrition in 1980 and 2008. Apportionment 2013;127:1493-502. 10.1161/CIRCULATIONAHA.113.001470 [PMC costless article] [PubMed] [CrossRef] [Google Scholar]
11. Danaei Grand, Ding EL, Mozaffarian D, et al. The preventable causes of expiry in the U.s.a.: comparative risk assessment of dietary, lifestyle, and metabolic gamble factors. PLoS Med 2009;6:e1000058. 10.1371/journal.pmed.1000058 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
thirteen. Wilkinson RG, Pickett KE. Income inequality and population health: a review and explanation of the bear witness. Soc Sci Med 2006;62:1768-84. 10.1016/j.socscimed.2005.08.036 [PubMed] [CrossRef] [Google Scholar]
fourteen. Leischik R, Dworrak B, Strauss G, et al. Plasticity of Health. High german Periodical of Medicine 2016;1:1-17. [Google Scholar]
15. Laatikainen T, Critchley J, Vartiainen E, et al. Explaining the refuse in coronary heart affliction mortality in Republic of finland between 1982 and 1997. Am J Epidemiol 2005;162:764-73. 10.1093/aje/kwi274 [PubMed] [CrossRef] [Google Scholar]
16. Writing Grouping Members , Mozaffarian D, Benjamin EJ, et al. Executive Summary: Center Disease and Stroke Statistics--2016 Update: A Written report From the American Heart Association. Circulation 2016;133:447-54. x.1161/CIR.0000000000000366 [PubMed] [CrossRef] [Google Scholar]
17. GBD 2013 Bloodshed and Causes of Expiry Collaborators. Global, regional, and national historic period-sex activity specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Brunt of Affliction Written report 2013. Lancet 2015;385:117-71. 10.1016/S0140-6736(14)61682-2 [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
18. Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart illness risk and prevalence. Arch Intern Med 2009;169:1762-6. ten.1001/archinternmed.2009.318 [PubMed] [CrossRef] [Google Scholar]
19. Deedwania PC, Carbajal EV. Silent myocardial ischemia. A clinical perspective. Curvation Intern Med 1991;151:2373-82. 10.1001/archinte.1991.00400120019004 [PubMed] [CrossRef] [Google Scholar]
xx. Roger VL, Weston SA, Killian JM, et al. Time trends in the prevalence of atherosclerosis: a population-based autopsy report. Am J Med 2001;110:267-73. 10.1016/S0002-9343(00)00709-9 [PubMed] [CrossRef] [Google Scholar]
21. Webber BJ, Seguin PG, Burnett DG, et al. Prevalence of and risk factors for autopsy-determined atherosclerosis amidst The states service members, 2001-2011. JAMA 2012;308:2577-83. 10.1001/jama.2012.70830 [PubMed] [CrossRef] [Google Scholar]
22. Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart disease. The Framingham Written report. Ann Intern Med 1978;89:157-61. 10.7326/0003-4819-89-two-157 [PubMed] [CrossRef] [Google Scholar]
23. Lerner DJ, Kannel WB. Patterns of coronary heart illness morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90. 10.1016/0002-8703(86)90155-nine [PubMed] [CrossRef] [Google Scholar]
24. Kannel WB. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected expiry. Apportionment 1987;75:II4-5. [PubMed] [Google Scholar]
25. Go AS, Iribarren C, Chandra M, et al. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 2006;144:229-38. 10.7326/0003-4819-144-four-200602210-00004 [PubMed] [CrossRef] [Google Scholar]
26. Ergin A, Muntner P, Sherwin R, et al. Secular trends in cardiovascular illness mortality, incidence, and instance fatality rates in adults in the U.s.a.. Am J Med 2004;117:219-27. 10.1016/j.amjmed.2004.03.017 [PubMed] [CrossRef] [Google Scholar]
27. Arciero TJ, Jacobsen SJ, Reeder GS, et al. Temporal trends in the incidence of coronary disease. Am J Med 2004;117:228-33. 10.1016/j.amjmed.2004.04.008 [PubMed] [CrossRef] [Google Scholar]
28. Yusuf Southward, Reddy Due south, Ounpuu S, et al. Global burden of cardiovascular diseases: Role II: variations in cardiovascular affliction by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64. ten.1161/hc4701.099488 [PubMed] [CrossRef] [Google Scholar]
29. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional brunt of disease and gamble factors, 2001: systematic analysis of population wellness data. Lancet 2006;367:1747-57. ten.1016/S0140-6736(06)68770-ix [PubMed] [CrossRef] [Google Scholar]
30. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: role I: general considerations, the epidemiologic transition, risk factors, and touch on of urbanization. Circulation 2001;104:2746-53. 10.1161/hc4601.099487 [PubMed] [CrossRef] [Google Scholar]
31. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006;124:235-44. [PubMed] [Google Scholar]
32. Critchley J, Liu J, Zhao D, et al. Explaining the increase in coronary center disease mortality in Beijing between 1984 and 1999. Circulation 2004;110:1236-44. 10.1161/01.CIR.0000140668.91896.AE [PubMed] [CrossRef] [Google Scholar]
33. Rodríguez T, Malvezzi G, Chatenoud Fifty, et al. Trends in bloodshed from coronary centre and cerebrovascular diseases in the Americas: 1970-2000. Centre 2006;92:453-threescore. 10.1136/hrt.2004.059295 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
34. Beaglehole R, Reddy S, Leeder SR. Poverty and human development: the global implications of cardiovascular disease. Circulation 2007;116:1871-3. 10.1161/CIRCULATIONAHA.107.736926 [PubMed] [CrossRef] [Google Scholar]
35. Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and hazard of myocardial infarction. JAMA 2014;312:1754-63. 10.1001/jama.2014.14681 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
36. Chow BJ, Pocket-size G, Yam Y, et al. Incremental prognostic value of cardiac computed tomography in coronary avenue disease using Ostend: COroNary computed tomography angiography evaluation for clinical outcomes: an InteRnational Multicenter registry. Circ Cardiovasc Imaging 2011;4:463-72. 10.1161/CIRCIMAGING.111.964155 [PubMed] [CrossRef] [Google Scholar]
37. Fleg JL, Forman DE, Berra K, et al. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation 2013;128:2422-46. 10.1161/01.cir.0000436752.99896.22 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
38. Yeh RW, Go Equally. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med 2010;170:759-64. 10.1001/archinternmed.2010.88 [PubMed] [CrossRef] [Google Scholar]
39. Furman MI, Dauerman HL, Goldberg RJ, et al. 20-two year (1975 to 1997) trends in the incidence, in-infirmary and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001;37:1571-80. 10.1016/S0735-1097(01)01203-7 [PubMed] [CrossRef] [Google Scholar]
40. Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and hospital mortality amidst patients with ST superlative and non-ST height myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Middle J 2008;156:1026-34. x.1016/j.ahj.2008.07.030 [PubMed] [CrossRef] [Google Scholar]
41. Chen J, Normand SL, Wang Y, et al. Contempo declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Apportionment 2010;121:1322-8. 10.1161/CIRCULATIONAHA.109.862094 [PubMed] [CrossRef] [Google Scholar]
42. Hardoon SL, Whincup PH, Lennon LT, et al. How much of the recent refuse in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Bear witness from a prospective population-based study. Circulation 2008;117:598-604. 10.1161/CIRCULATIONAHA.107.705947 [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]
43. Roger VL, Weston SA, Gerber Y, et al. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Apportionment 2010;121:863-9. ten.1161/CIRCULATIONAHA.109.897249 [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
44. Parikh NI, Gona P, Larson MG, et al. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Claret Institute'south Framingham Heart report. Circulation 2009;119:1203-ten. 10.1161/CIRCULATIONAHA.108.825364 [PMC costless article] [PubMed] [CrossRef] [Google Scholar]
45. Watkins S, Thiemann D, Coresh J, et al. 14-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-acme acute coronary syndromes in iv United states communities. Am J Cardiol 2005;96:1349-55. 10.1016/j.amjcard.2005.07.037 [PubMed] [CrossRef] [Google Scholar]
46. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart illness, 1987 to 1994. N Engl J Med 1998;339:861-seven. 10.1056/NEJM199809243391301 [PubMed] [CrossRef] [Google Scholar]
47. Goldberg RJ, Yarzebski J, Lessard D, et al. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term instance-fatality rates of astute myocardial infarction: a customs-wide perspective. J Am Coll Cardiol 1999;33:1533-nine. x.1016/S0735-1097(99)00040-half dozen [PubMed] [CrossRef] [Google Scholar]
48. Goldberg RJ, Glatfelter One thousand, Burbank-Schmidt East, et al. Trends in community mortality due to coronary heart disease. Am Heart J 2006;151:501-7. 10.1016/j.ahj.2005.04.024 [PubMed] [CrossRef] [Google Scholar]
49. Goldberg RJ, McCormick D, Gurwitz JH, et al. Age-related trends in brusk- and long-term survival after astute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 1998;82:1311-seven. x.1016/S0002-9149(98)00633-10 [PubMed] [CrossRef] [Google Scholar]
50. McGovern PG, Jacobs DR, Jr, Shahar E, et al. Trends in acute coronary heart affliction mortality, morbidity, and medical care from 1985 through 1997: the Minnesota centre survey. Circulation 2001;104:19-24. x.1161/01.CIR.104.i.nineteen [PubMed] [CrossRef] [Google Scholar]
51. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136:341-8. 10.7326/0003-4819-136-5-200203050-00005 [PubMed] [CrossRef] [Google Scholar]
52. Myerson M, Coady S, Taylor H, et al. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009;119:503-14. x.1161/CIRCULATIONAHA.107.693879 [PubMed] [CrossRef] [Google Scholar]
53. Yeh RW, Sidney S, Chandra K, et al. Population trends in the incidence and outcomes of astute myocardial infarction. N Engl J Med 2010;362:2155-65. 10.1056/NEJMoa0908610 [PubMed] [CrossRef] [Google Scholar]
54. American Diabetes Association . 8. Cardiovascular Disease and Take chances Direction. Diabetes Care 2016;39 Suppl 1:S60-71. 10.2337/dc16-S011 [PubMed] [CrossRef] [Google Scholar]
55. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001;135:801-eleven. 10.7326/0003-4819-135-9-200111060-00010 [PubMed] [CrossRef] [Google Scholar]
56. Kannel WB, Cupples LA, Gagnon DR. Incidence, precursors and prognosis of unrecognized myocardial infarction. Adv Cardiol 1990;37:202-fourteen. 10.1159/000418828 [PubMed] [CrossRef] [Google Scholar]
57. Kannel WB. Lipids, diabetes, and coronary heart illness: insights from the Framingham Report. Am Heart J 1985;110:1100-7. 10.1016/0002-8703(85)90224-8 [PubMed] [CrossRef] [Google Scholar]
58. Sigurdsson E, Thorgeirsson G, Sigvaldason H, et al. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Written report. Ann Intern Med 1995;122:96-102. 10.7326/0003-4819-122-2-199501150-00003 [PubMed] [CrossRef] [Google Scholar]
59. Jónsdóttir LS, Sigfusson North, Sigvaldason H, et al. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Centre J 1998;19:1011-8. 10.1053/euhj.1998.0980 [PubMed] [CrossRef] [Google Scholar]
sixty. de Torbal A, Boersma E, Kors JA, et al. Incidence of recognized and unrecognized myocardial infarction in men and women anile 55 and older: the Rotterdam Study. Eur Eye J 2006;27:729-36. 10.1093/eurheartj/ehi707 [PubMed] [CrossRef] [Google Scholar]
61. Guidry UC, Evans JC, Larson MG, et al. Temporal trends in issue rates subsequently Q-moving ridge myocardial infarction: the Framingham Heart Study. Circulation 1999;100:2054-nine. x.1161/01.CIR.100.xx.2054 [PubMed] [CrossRef] [Google Scholar]
62. Davidoff R, Goldman AP, Diamond Thursday, et al. The natural history of the Q wave in inferoposterior myocardial infarction. Southward Afr Med J 1982;61:611-2. [PubMed] [Google Scholar]
63. Richter A, Herlitz J, Hjalmarson A. QRS complex recovery during one year after astute myocardial infarction. Clin Cardiol 1987;x:16-20. 10.1002/clc.4960100105 [PubMed] [CrossRef] [Google Scholar]
64. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study. Am Center J 1986;111:391-7. 10.1016/0002-8703(86)90156-0 [PubMed] [CrossRef] [Google Scholar]
65. Levy D, Salomon M, D'Agostino RB, et al. Prognostic implications of baseline electrocardiographic features and their series changes in subjects with left ventricular hypertrophy. Apportionment 1994;90:1786-93. ten.1161/01.CIR.xc.four.1786 [PubMed] [CrossRef] [Google Scholar]
66. Kors JA, de Bruyne MC, Hoes AW, et al. T axis as an indicator of gamble of cardiac events in elderly people. Lancet 1998;352:601-5. 10.1016/S0140-6736(97)10190-eight [PubMed] [CrossRef] [Google Scholar]
67. Rautaharju PM, Nelson JC, Kronmal RA, et al. Usefulness of T-axis deviation as an independent adventure indicator for incident cardiac events in older men and women free from coronary center affliction (the Cardiovascular Wellness Study). Am J Cardiol 2001;88:118-23. 10.1016/S0002-9149(01)01604-half dozen [PubMed] [CrossRef] [Google Scholar]
68. Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J 1985;109:581-5. x.1016/0002-8703(85)90566-6 [PubMed] [CrossRef] [Google Scholar]
69. Shlipak MG, Elmouchi DA, Herrington DM, et al. The incidence of unrecognized myocardial infarction in women with coronary eye affliction. Ann Intern Med 2001;134:1043-seven. 10.7326/0003-4819-134-eleven-200106050-00010 [PubMed] [CrossRef] [Google Scholar]
70. Orencia A, Bailey K, Yawn BP, et al. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. JAMA 1993;269:2392-vii. 10.1001/jama.1993.03500180084039 [PubMed] [CrossRef] [Google Scholar]
71. Hemingway H, McCallum A, Shipley Thou, et al. Incidence and prognostic implications of stable angina pectoris amongst women and men. JAMA 2006;295:1404-11. 10.1001/jama.295.12.1404 [PubMed] [CrossRef] [Google Scholar]
72. LaCroix AZ, Guralnik JM, Adjourn JD, et al. Chest hurting and coronary middle disease mortality amid older men and women in 3 communities. Circulation 1990;81:437-46. 10.1161/01.CIR.81.ii.437 [PubMed] [CrossRef] [Google Scholar]
73. Maddox TM, Reid KJ, Spertus JA, et al. Angina at 1 twelvemonth later on myocardial infarction: prevalence and associated findings. Curvation Intern Med 2008;168:1310-six. x.1001/archinte.168.12.1310 [PubMed] [CrossRef] [Google Scholar]
74. White Hard disk, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction take the same bloodshed and morbidity every bit men except for a college incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation 1993;88:2097-103. 10.1161/01.CIR.88.5.2097 [PubMed] [CrossRef] [Google Scholar]
75. Maynard C, Litwin PE, Martin JS, et al. Gender differences in the treatment and result of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Curvation Intern Med 1992;152:972-6. 10.1001/archinte.1992.00400170062012 [PubMed] [CrossRef] [Google Scholar]
76. Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997;30:141-eight. 10.1016/S0735-1097(97)00107-1 [PubMed] [CrossRef] [Google Scholar]
77. Chang WC, Kaul P, Westerhout CM, et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med 2003;163:2476-84. 10.1001/archinte.163.twenty.2476 [PubMed] [CrossRef] [Google Scholar]
78. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. Northward Engl J Med 1999;341:226-32. 10.1056/NEJM199907223410402 [PubMed] [CrossRef] [Google Scholar]
79. Roger VL, Farkouh ME, Weston SA, et al. Sex differences in evaluation and issue of unstable angina. JAMA 2000;283:646-52. ten.1001/jama.283.5.646 [PubMed] [CrossRef] [Google Scholar]
80. Kuulasmaa 1000, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic take chances factors to trends in coronary-event rates across the WHO MONICA Projection populations. Lancet 2000;355:675-87. 10.1016/S0140-6736(99)11180-2 [PubMed] [CrossRef] [Google Scholar]
81. McGovern PG, Pankow JS, Shahar East, et al. Contempo trends in astute coronary center disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-ninety. 10.1056/NEJM199604043341403 [PubMed] [CrossRef] [Google Scholar]
82. Capewell Due south, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and hazard cistron changes to the refuse in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999;81:380-6. 10.1136/hrt.81.four.380 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
83. Capewell S, Beaglehole R, Seddon M, et al. Caption for the decline in coronary heart disease mortality rates in Auckland, New Zealand, betwixt 1982 and 1993. Circulation 2000;102:1511-6. 10.1161/01.CIR.102.13.1511 [PubMed] [CrossRef] [Google Scholar]
84. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart affliction, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular affliction prevention. Circulation 2000;102:3137-47. x.1161/01.CIR.102.25.3137 [PubMed] [CrossRef] [Google Scholar]
85. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. Due north Engl J Med 2007;356:2388-98. ten.1056/NEJMsa053935 [PubMed] [CrossRef] [Google Scholar]
86. Tu JV, Nardi Fifty, Fang J, et al. National trends in rates of decease and infirmary admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009;180:E118-25. x.1503/cmaj.081197 [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
87. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular illness mortality amidst women and men with and without diabetes mellitus in the Framingham Centre Report, 1950 to 2005. Circulation 2009;119:1728-35. x.1161/CIRCULATIONAHA.108.829176 [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
88. Fox CS, Coady South, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Apportionment 2007;115:1544-fifty. 10.1161/CIRCULATIONAHA.106.658948 [PubMed] [CrossRef] [Google Scholar]
89. Levi F, Lucchini F, Negri Due east, et al. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88:119-24. ten.1136/eye.88.2.119 [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
90. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med 2004;350:2438-xl. 10.1056/NEJMp048024 [PubMed] [CrossRef] [Google Scholar]
91. Okrainec G, Banerjee DK, Eisenberg MJ. Coronary avenue disease in the developing world. Am Heart J 2004;148:seven-15. ten.1016/j.ahj.2003.11.027 [PubMed] [CrossRef] [Google Scholar]
92. Montagnana M, Lippi Chiliad, Franchini M, et al. Sudden cardiac death: prevalence, pathogenesis, and prevention. Ann Med 2008;40:360-75. 10.1080/07853890801964930 [PubMed] [CrossRef] [Google Scholar]
93. Kannel WB, Thomas HE, Jr. Sudden coronary death: the Framingham Study. Ann N Y Acad Sci 1982;382:3-21. x.1111/j.1749-6632.1982.tb55203.x [PubMed] [CrossRef] [Google Scholar]
94. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac expiry in the United States, 1989 to 1998. Circulation 2001;104:2158-63. 10.1161/hc4301.098254 [PubMed] [CrossRef] [Google Scholar]
95. Byrne R, Constant O, Smyth Y, et al. Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur Heart J 2008;29:1418-23. x.1093/eurheartj/ehn155 [PubMed] [CrossRef] [Google Scholar]
96. Andréoletti L, Ventéo L, Douche-Aourik F, et al. Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol 2007;50:2207-fourteen. ten.1016/j.jacc.2007.07.080 [PubMed] [CrossRef] [Google Scholar]
97. Gillum RF. Sudden coronary death in the United States: 1980-1985. Apportionment 1989;79:756-65. 10.1161/01.CIR.79.4.756 [PubMed] [CrossRef] [Google Scholar]
98. Kannel WB, Wilson Pw, D'Agostino RB, et al. Sudden coronary death in women. Am Heart J 1998;136:205-12. 10.1053/hj.1998.v136.90226 [PubMed] [CrossRef] [Google Scholar]
99. Berger CJ, Murabito JM, Evans JC, et al. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA 1992;268:1545-51. ten.1001/jama.1992.03490120059029 [PubMed] [CrossRef] [Google Scholar]
100. Kannel WB, Cupples LA, D'Agostino RB. Sudden death gamble in overt coronary middle disease: the Framingham Report. Am Heart J 1987;113:799-804. 10.1016/0002-8703(87)90722-8 [PubMed] [CrossRef] [Google Scholar]
101. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by northward-three polyunsaturated fat acids later on myocardial infarction: time-grade assay of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903. x.1161/01.CIR.0000014682.14181.F2 [PubMed] [CrossRef] [Google Scholar]
102. Torp-Pedersen C, Kober L. Result of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular office after acute myocardial infarction. TRACE Study Grouping. Trandolapril Cardiac Evaluation. Lancet 1999;354:9-12. ten.1016/S0140-6736(98)09374-X [PubMed] [CrossRef] [Google Scholar]
103. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Construction, function, and time-dependence of chance. Circulation 1992;85:I2-10. [PubMed] [Google Scholar]
104. Chugh SS, Uy-Evanado A, Teodorescu C, et al. Women take a lower prevalence of structural heart disease as a forerunner to sudden cardiac abort: The Ore-SUDS (Oregon Sudden Unexpected Death Report). J Am Coll Cardiol 2009;54:2006-11. 10.1016/j.jacc.2009.07.038 [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
105. Kim C, Fahrenbruch CE, Cobb LA, et al. Out-of-hospital cardiac arrest in men and women. Circulation 2001;104:2699-703. ten.1161/hc4701.099784 [PubMed] [CrossRef] [Google Scholar]
Articles from Annals of Translational Medicine are provided hither courtesy of AME Publications
robertsonandeten73.blogspot.com
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958723/
0 Response to "Hesi Review Care of Patient With Acute Coronary Syndrome Chapter 38"
Post a Comment